Healthcare of Ontario Pension Plan Trust Fund Grows Stock Holdings in Cemex S.A.B. de C.V. $CX

Healthcare of Ontario Pension Plan Trust Fund increased its position in Cemex S.A.B. de C.V. (NYSE:CX) by 1,747.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 3,646,000 shares of the construction company’s stock after buying an additional 3,448,600 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Cemex were worth $41,710,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of CX. Sequoia Financial Advisors LLC increased its stake in Cemex by 5.7% in the 4th quarter. Sequoia Financial Advisors LLC now owns 16,802 shares of the construction company’s stock worth $193,000 after buying an additional 913 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of Cemex by 0.4% in the third quarter. Ameriprise Financial Inc. now owns 319,835 shares of the construction company’s stock valued at $2,875,000 after acquiring an additional 1,221 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cemex by 4.7% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 28,609 shares of the construction company’s stock valued at $329,000 after acquiring an additional 1,288 shares in the last quarter. Ieq Capital LLC boosted its stake in shares of Cemex by 7.6% in the fourth quarter. Ieq Capital LLC now owns 19,598 shares of the construction company’s stock worth $225,000 after acquiring an additional 1,380 shares during the period. Finally, Mercer Global Advisors Inc. ADV boosted its stake in shares of Cemex by 3.3% in the third quarter. Mercer Global Advisors Inc. ADV now owns 43,093 shares of the construction company’s stock worth $387,000 after acquiring an additional 1,389 shares during the period. Institutional investors own 82.97% of the company’s stock.

Insiders Place Their Bets

In other Cemex news, insider Herrera Jesus Vicente Gonzalez sold 35,000 shares of Cemex stock in a transaction that occurred on Tuesday, April 28th. The stock was sold at an average price of $12.16, for a total value of $425,600.00. Following the sale, the insider owned 846,010 shares of the company’s stock, valued at $10,287,481.60. The trade was a 3.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.00% of the stock is owned by corporate insiders.

Cemex Stock Down 1.5%

CX opened at $12.07 on Friday. The company has a market capitalization of $17.49 billion, a PE ratio of 35.52 and a beta of 1.52. The firm has a 50-day simple moving average of $12.57 and a two-hundred day simple moving average of $12.23. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.35. Cemex S.A.B. de C.V. has a 52 week low of $8.15 and a 52 week high of $13.67.

Cemex (NYSE:CX) last issued its earnings results on Thursday, July 23rd. The construction company reported $0.24 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.24. The firm had revenue of $4.59 billion for the quarter, compared to analysts’ expectations of $4.46 billion. Cemex had a return on equity of 3.76% and a net margin of 2.83%. Analysts forecast that Cemex S.A.B. de C.V. will post 0.87 earnings per share for the current fiscal year.

Cemex Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, June 29th. Shareholders of record on Wednesday, June 17th were issued a dividend of $0.0312 per share. The ex-dividend date was Wednesday, June 17th. This represents a $0.12 annualized dividend and a yield of 1.0%. This is a boost from Cemex’s previous quarterly dividend of $0.02. Cemex’s dividend payout ratio (DPR) is 37.50%.

Analyst Ratings Changes

Several research firms recently issued reports on CX. Wall Street Zen upgraded Cemex from a “hold” rating to a “buy” rating in a research report on Saturday, May 23rd. Santander raised Cemex to an “outperform” rating in a report on Thursday, June 11th. Scotiabank upped their price target on Cemex from $14.10 to $14.50 and gave the stock an “outperform” rating in a research note on Tuesday, July 14th. Barclays increased their price objective on shares of Cemex from $15.00 to $16.00 and gave the company an “overweight” rating in a report on Friday. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Cemex from $14.50 to $15.00 and gave the company an “overweight” rating in a research report on Wednesday, July 8th. Seven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cemex presently has a consensus rating of “Moderate Buy” and an average price target of $13.07.

Cemex Company Profile

Cemex (NYSE: CX) is a global building materials company headquartered in Monterrey, Mexico. The company produces, distributes and sells cement, ready-mix concrete and aggregates, as well as related building materials, to construction markets in more than 50 countries. Cemex’s product portfolio also includes asphalt and mortar mixes, waste-derived fuels and other complementary construction solutions, supported by a network of production facilities, distribution centers and logistics operations.

Founded in 1906 as Cementos Hidalgo, the company adopted the Cemex name in 1976 following a series of domestic mergers and expansions.